New treatment avenues in squamous cell carcinoma
26 Jul 2017
New treatment avenues in squamous cell carcinoma
New treatments for lung cancer
The unmet needs of cancer survivors
Precision medicine: a nurses perspective
Lung cancer advances beyond PD1
Identifying rare mutations in lung cancer
Targeting EGFR and ALK mutations
Abiraterone for metastatic, hormone sensitive, prostate cancer
New drug advancements presented at ASCO
The Bonnie J Addario Lung Cancer Foundation
iManageCancer: Psycho-emotional and family resilience monitoring
Celebrating a 10 year partnership: ecancer and the IEO